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doi:10.1Objective: Ibuprofen has been shown to reduce cerebral ischemic injury, such as may occur after deep hypother-
mic circulatory arrest. We investigated whether ibuprofen has direct protective effects against excitotoxic neuro-
nal injury, as may be seen after cerebral ischemia, by using a cell culture model.
Methods: Mixed cortical cultures containing neuronal and glial cells were prepared from fetal mice at 13 to 15
days gestation, plated on a layer of confluent astrocytes from 1- to 3-day-old postnatal pups. Near-pure neuronal
cultures containing less than 5% astrocytes were obtained from mice of the same gestational stage. Slowly trig-
gered excitotoxic injury was induced at 37C by 24-hour exposure to 12.5 mmol/L N-methyl-D-aspartate or 50
mmol/L kainate. Neuronal death was quantified by release of lactate dehydrogenase from damaged cells. Data
were analyzed using 1-way analysis of variance with Tukey post hoc multiple comparisons.
Results: In mixed cultures, ibuprofen concentrations of 25 mg/mL, 50 mg/mL, and 100 mg/mL all significantly
reduced N-methyl-D-aspartate–induced neuronal cell death from 74.5% to 56.1%, 38.7%, and 12.3%, respec-
tively, revealing a strong dose response (P<.001). In near-pure cultures, ibuprofen at a concentration of 25 mg/
mL failed to protect neurons, indicating that the neuroprotective effects of ibuprofen require interaction with glial
cells. Furthermore, ibuprofen at 100 mg/mL was not protective against neuronal cell death induced by kainate
exitotoxicity in near-pure culture but was effective in mixed cultures.
Conclusion: Ibuprofen provides neuroprotection through glial cells against excitotoxic neuronal injury caused by
glutamatergic excitotoxicity after cerebral ischemia as demonstrated by reduced neuronal cell death in mixed cell
cultures. Further studies are needed to evaluate the potential of ibuprofen to reduce neurologic injury in patients
experiencing an hypoxic/ischemic insult. (J Thorac Cardiovasc Surg 2010;139:489-93)Low-flow cardiopulmonary bypass and deep hypothermic
circulatory arrest are used to facilitate pediatric cardiac sur-
gery, although they carry a risk of ischemic brain damage.
There are also deleterious effects of cardiopulmonary by-
pass, such as inflammation, which may exacerbate ischemic
brain injury. Ibuprofen is a nonsteroidal anti-inflammatory
drug that is widely used to reduce pain, fever, and inflamma-
tion. The drug inhibits cyclooxygenase and activates perox-
isome proliferator-activated receptors; both of these actions
result in reduced inflammation.1-3 Ibuprofen has been shown
to reduce cerebral ischemic injury and infarct size, such as
may occur after deep hypothermic circulatory arrest.4,5 Ibu-
profen has been reported to improve cerebral blood flow af-
ter global cerebral ischemia and to restore cerebral
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MIt is well known that ischemia can cause neuronal cell
death through the mechanism of glutamatergic excitotoxic-
ity. An ischemic insult initially impairs glutamate transpor-
tation at the postsynaptic level and increases extracellular
glutamate levels, resulting in glutamatergic excitotoxicity,
which is excessive neuronal excitation mediated by exces-
sive calcium influx. Thus, neurologic problems after cardiac
surgery, such as may occur with circulatory arrest, embolic
injury, or low-flow states, may be a result of excitotoxicity
after cerebral ischemia.
Glutamate is the principal neurotransmitter at the majority
of synapses throughout the brain and spinal cord. N-methyl-
D-aspartate (NMDA), AMPA, and kainate are glutamate re-
ceptor subtypes defined by their response to these agents; the
NMDA pathway causes neuronal injury more rapidly than
the AMPA or kainate pathway, reflecting a greater ability
to induce calcium influx. Rapidly triggered excitotoxicity
can be separated into 2 components: (1) immediate neuronal
cell swelling induced by the influx of extracellular Na and
(2) delayed neuronal cell degeneration induced by excessive
Ca influx. AMPA, kainate, and NMDA receptors all contrib-
ute to the neuronal cell swelling seen with excitotoxic injury.
In contrast, NMDA receptor activation is necessary and suf-
ficient to induce delayed neuronal cell degeneration. Al-
though either the acute cell swelling or delayed neuronal
cell degeneration can alone produce irreversible neuronal in-
jury, under certain conditions the majority of cells canrdiovascular Surgery c Volume 139, Number 2 489
Abbreviations and Acronyms
DIV ¼ days in vitro
LDH ¼ lactate dehydrogenase
NMDA ¼ N-methyl-D-aspartate
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Mrecover and survive from cell swelling. Generally most cor-
tical neurons die through delayed neuronal degeneration.8
The purpose of the current study was to investigate
whether ibuprofen has direct neuroprotective effects against
excitotoxic neuronal cell death induced by NMDA and kai-
nate using a neuronal cell culture model.MATERIALS AND METHODS
Near-Pure Neuronal Cultures
Near-pure neuronal cultures containing less than 5% astrocytes were ob-
tained from fetal mice at 13 to 15 days gestation (Taconic, Rockville, Md).
Dissociated cortical cells in plating medium of media stock (Dulbecco’s
modified Eagle’s medium with 25 mmol/L glucose; Sigma, St Louis,
MO) supplemented with 5% fetal bovine serum (Gibco, Carlsbad, Calif),
5% horse serum (Gibco), and 2 mmol/L glutamine (Sigma) were plated
in 24-well plates coated with poly-D-lysine (0.1 mg/dL; Invitrogen, Carls-
bad, Calif) and laminin (0.02 mg/mL; Invitrogen). After 3 days in vitro
(DIV), non-neuronal cell division was halted by exposure to 10 mmol/L cy-
tosine arabinoside (Ara-C; Sigma). There was no further exchange of the
media except adding Dulbecco’s modified Eagle’s medium for evaporation.
After 12 DIV, cultures did not need the presence of serum to survive. They
were shifted to a maintenance medium identical to plating medium but lack-FIGURE 1. A, Shamwash (mixed cortical cultures). B, Ibuprofen (100 mg/mL) a
hours and demonstrated an acute swelling of neuronal cell bodies followed by a w
segmentalized neuritis. D, Ibuprofen at a concentration of 100 mg/mLwas co-app
cells and protected neurites. Original magnification is 2003. Scale bars ¼ 100
490 The Journal of Thoracic and Cardiovascular Surging serum. All cultures were kept at 37C in a humidified 5% CO2 incuba-
tor. Cultures were used after 13 to 14 DIV for excitotoxic injury.9
Glial Cultures
Glial cell cultures were prepared from 1- to 3-day-old postnatal mice
(1–3 days after birth from Taconic, Rockville, Md). Dissociated cortical
cells were plated in 24-well plates previously coated with poly-D-lysine
(0.1 mg/dL) using a plating medium of media stock supplemented with
10% horse serum, 10% fetal bovine serum, and 2 mmol/L glutamine.
Cultures were kept at 37C in a humidified 5% CO2-containing atmosphere
until they reached confluency, 7 to 14 DIV. Confluent cultures were then
used as a support for mixed cultures.9
Mixed Cortical Cultures
Mixed cortical cultures containing both neurons and astrocytes were pre-
pared from fetal mice at 13 to 15 days gestation. Dissociated cortical cells
were plated in 24 wells on a layer of confluent astrocytes, using plating me-
dium supplemented with 5% horse serum, 5% fetal bovine serum, and 2
mmol/L glutamine. After 7 DIV, non-neuronal cell division was halted by
a 2 to 3 days of exposure to 10 mmol/L Ara-C. Subsequent partial medium
replacement was performed twice per week, and after 12 DIV, cultures were
shifted to a maintenance medium identical to platingmedium although lack-
ing serum because neurons survive without it. Experiments were performed
on cortical cultures after 13 to 14 DIV.9
Slowly Triggered Excitotoxicity
Because lower levels of glutamate exposure induce delayed neuronal cell
death in most cortical neurons, slowly triggered excitotoxicity was induced
at 37C by 24-hour exposure to 12.5 mmol/L NMDA or 50 mmol/L kainate
as an excitotoxin in media stock supplemented with 10 mmol/L glycine.
These concentrations do not influence glial cells; 10 mmol/L MK-801 was
always added concurrently with kainate to block secondary NMDA receptorlone. C,Mixed cortical cultures were exposed to 12.5 mmol/L NMDA for 24
idespread necrotic neuronal degeneration resulting in disrupted neurons and
lied in the mediumwith excitotoxin (NMDA). Ibuprofen preserved neuronal
mm. NMDA, N-methyl-D-aspartate; Ib, ibuprofen.
ery c February 2010
FIGURE 2. Exposure to 12.5 mmol/L NMDA revealed approximately 70% neuronal cell death by LDH assay measuring LDH levels in bathing medium in
both cultures. Ibuprofen at a concentration of 25 mg/mL, 50 mg/mL, and 100 mg/mL reduced neuronal cell death significantly from 74.5% 3.8% to 56.1%
4.0%, 38.7%  2.8%, and 12.3%  1.4% in mixed cultures, respectively, revealing a strong dose response (P< .001). However low-concentration
ibuprofen failed to protect neurons in near-pure cultures. A, Mixed cultures. B, Near-pure cultures. *Significantly different from NMDA alone by analysis
of variance with Tukey correction (mean  standard error).
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Mactivation.9 Ibuprofen was co-applied at 3 different concentrations, 25 mg/
mL, 50 mg/mL, or 100 mg/mL, with the excitotoxin and left for 24 hours
in the bathing medium. A clinically effective concentration of ibuprofen
is between 25 and 100 mg/mL because the inhibitory effect of ibuprofen
on neutrophil activation and migration generally occurs at concentrations
greater than 50 mg/mL.10
Assessment of Neuronal Cell Death
The percentage of neuronal cell death was calculated by lactate dehydro-
genase (LDH) assay, which is a standard method that is widely applied for
quantitation of cell death in neuronal cell culture.8,9,11 Briefly, neuronal
death was confirmed qualitatively by examining cultures under phase-con-
trast microscopy and was quantified by measurement of LDH release from
damaged cells into the bathing medium 24 hours after the onset of excito-
toxin exposure. Only damaged cells (dead neurons) release LDH. LDH
was measured by ELISA kit (Promega, Madison, Wis). The percentage of
neuronal cell death was calculated by LDH levels in the bathing medium.
The LDH level corresponding to complete neuronal death (without glial
death) was determined in sister cultures exposed to 100 mmol/L NMDA.
Background LDH levels were determined in sister cultures with sham
wash as a control and subtracted from experimental values to yield the signal
specific for experimentally induced injury.11
Statistical Analysis
The primary outcome measure for evaluating efficacy was percentage of
neuronal cell death calculated by LDH levels. Results are expressed as mean
 standard error. When n ¼ 12 is indicated, this value corresponds to 12The Journal of Thoracic and Cadifferent well pools derived from 3 different dissections. Analysis of these
data included factorial 1-way analysis of variance with the Tukey post hoc
method for multiple group comparisons to protect against type I (false-pos-
itive) results.12 The Statistical Package for the Social Sciences was used for
statistical analysis (version 15.1; SPSS Inc, Chicago, Ill). Power analysis in-
dicated that the sample sizes provided 80% power to detect a significant dif-
ference in neuronal cell death of 15% or more between treatment groups
assuming a standard deviation of 5% to 10% (version 7.0; nQuery Advisor,
Statistical Solutions, Saugus, Mass).RESULTS
Shamwash and addition of ibuprofen alone at the concen-
tration of 100 mg/mL did not influence neuronal cells in ei-
ther mixed or pure neuronal culture (Figure 1, A, B).
Excitotoxicity was induced by exposure to 12.5 mmol/L
NMDA or 50 mmol/L kainate for 24 hours and demonstrated
an acute swelling of neuronal cell bodies followed by wide-
spread necrotic neuronal degeneration resulting in disrupted
neurons and segmentalized neurites in both near-pure and
mixed cultures (Figure 1, C). Ibuprofen at a concentration
of 100 mg/mL was co-applied in the medium with excito-
toxin (NMDA). Ibuprofen was able to preserve neuronal
cells, including neurites in both cultures (Figure 1,D). Expo-
sure to 12.5 mmol/L NMDA revealed approximately 70%rdiovascular Surgery c Volume 139, Number 2 491
FIGURE 3. Exposure to 50 mmol/L kainate revealed approximately 30%
neuronal cell death. Ibuprofen reduced neuronal cell death induced by expo-
sure to 50 mmol/L kainate from 36.1% 3.5% to 20.0% 3.1% in mixed
cultures but failed in near-pure cultures. A, Mixed cultures. B, Near-pure
cultures. *Significantly different from kainate alone by analysis of variance
with Tukey correction (mean  standard error).
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Mneuronal cell death by LDH assay, measuring LDH levels in
bathing medium in both cultures. Ibuprofen at a concentra-
tion of 25 mg/mL, 50 mg/mL, and 100 mg/mL reduced
neuronal cell death significantly from 74.5%  3.8% to
56.1%  4.0%, 38.7%  2.8%, and 12.3%  1.4% in
mixed cultures, respectively, revealing a strong dose-re-
sponse (P< .001). However, low-concentration ibuprofen
failed to protect neurons in near-pure cultures (Figure 2,
A, B). Exposure to 50 mmol/L kainate revealed approxi-
mately 30% neuronal cell death. Ibuprofen also reduced
neuronal cell death induced by exposure to 50 mmol/L kai-
nate from 36.1%  3.5% to 20.0%  3.1% in mixed cul-
tures but failed in near-pure cultures (Figure 3, A, B). These
results suggest that ibuprofen may reduce glutamatergic ex-
citotoxic neuronal cell death induced by NMDA or kainate,
resulting from ischemia, although it may require interaction
with glial cells.DISCUSSION
This study demonstrated that ibuprofen protects neu-
rons against glutamatergic excitotoxic neuronal cell death
induced by NMDA or kainate in mixed cortical cultures.
However, ibuprofen fails to reduce neuronal cell death in492 The Journal of Thoracic and Cardiovascular Surgnear-pure cultures. This result suggests that protection of
neurons by ibuprofen requires interaction with glial cells
and is not a result of a direct effect on neurons. Further
evidence for the role of glial cells is the observation
that the percentage of neuronal cell death was the same
whether induced by NMDA or kainate in both cultures.
It is possible that ibuprofen stimulates glial cells to re-
lease a neuroprotective mediator, such as a cytokine, or
inhibits the deleterious effects of mediators released by
glial cells.
It is thought that inflammation contributes to post-ische-
mic brain injury. Although cytokines are produced in the
central nervous system by other cells, including astrocytes,
neurons, and endothelial cells, microglia rapidly respond
to injury by secreting inflammatory cytokines on injury.
Proinflammatory cytokines, such as interleukin-1b and tu-
mor necrosis factor-a, are involved in ischemia/hypoxia
and trauma-induced brain injury.13,14 Ibuprofen is a nonste-
roidal anti-inflammatory drug and is widely used to reduce
pain, fever, and inflammation. The drug inhibits cycloox-
ygenase and activates peroxisome proliferator-activated
receptors; both of these actions result in reduced inflam-
mation.1-3 Park and coworkers5 described ibuprofen
protecting neurons against ischemia via up-regulating in-
terleukin-1 receptor antagonist expression. However, inhi-
bition of cyclooxygenase has been controversial in adult
cardiac surgery in regard to cardiac protection. McGuin-
ness and coworkers15 reported that glutamine pretreatment
conferred infarct protection through up-regulation of cy-
clooxygenase-2. Wong and colleagues16 reported that a se-
lective cyclooxygenase-2 inhibitor did not affect the
myocardium in patients undergoing coronary artery bypass
grafting.
Local cerebral glucose use decreases after traumatic brain
injury as live cells decrease in number. Pappius and Wolfe6
demonstrated that pretreatment with ibuprofen prevented the
depression of local cerebral glucose use after traumatic brain
injury. They suggested that ibuprofen protected neurons and
improved cerebral metabolism after brain injury and that
these effects might be associated with suppression of prosta-
glandin synthesis.
Cerebral blood flow usually decreases after cerebral ische-
mia because of vasoconstriction resulting from hypoperfu-
sion during ischemia and subsequent inflammation. Grice
and colleagues7 reported that ibuprofen improved post-is-
chemic hypoperfusion after normothermic global cerebral
ischemia in dogs, although cerebral blood flow did not return
to normal. They demonstrated that ibuprofen suppressed the
production of thromboxane B2 and prostaglandin I2 after
global cerebral ischemia.7 Ibuprofen has been reported to re-
duce infarct size after temporary cerebral ischemia, for ex-
ample, after deep hypothermic circulatory arrest.4 They
suggested that the beneficial effect of cyclooxygenase inhi-
bition occurs during reperfusion.ery c February 2010
Iwata et al Perioperative ManagementCONCLUSIONS
Ibuprofen provides neuroprotection through glial cells
against glutamatergic excitotoxicity as demonstrated by re-
duced neuronal cell death in mixed cell cultures. Further
studies regarding mechanisms at the molecular level and
with whole animal models are needed to assess the potential
of ibuprofen to reduce neurologic injury in patients undergo-
ing circulatory arrest and cardiopulmonary bypass.
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